ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
109.92
-1.98 (-1.77%)
At close: Apr 28, 2026, 4:00 PM EDT
109.87
-0.05 (-0.04%)
After-hours: Apr 28, 2026, 4:00 PM EDT
ABIVAX Société Anonyme Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for ABIVAX Société Anonyme stock have an average target of 131.31, with a low estimate of 70 and a high estimate of 176. The average target predicts an increase of 19.47% from the current stock price of 109.92.
Analyst Consensus: Buy
* Price targets were last updated on Mar 24, 2026.
Analyst Ratings
The average analyst rating for ABIVAX Société Anonyme stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 9 | 9 | 9 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $142 → $148 | Buy | Maintains | $142 → $148 | +34.65% | Mar 24, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $160 | Strong Buy | Initiates | $160 | +45.57% | Mar 16, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +36.47% | Feb 25, 2026 |
| Wedbush | Wedbush | Sell Initiates $110 | Sell | Initiates | $110 | +0.08% | Feb 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $101 → $145 | Buy | Maintains | $101 → $145 | +31.92% | Jan 9, 2026 |
Financial Forecast
Revenue This Year
6.95M
from 4.57M
Increased by 52.14%
Revenue Next Year
294.27M
from 6.95M
Increased by 4,132.27%
EPS This Year
-0.59
from -4.83
EPS Next Year
-2.75
from -0.59
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 13.0M | 630.5M | ||||||
| Avg | 7.0M | 294.3M | ||||||
| Low | 3.9M | 110.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 184.9% | 8,968.5% | ||||||
| Avg | 52.1% | 4,132.3% | ||||||
| Low | -14.2% | 1,492.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 10.50 | -2.03 | ||||
| Avg | -0.59 | -2.75 | ||||
| Low | -3.20 | -3.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.